GSM4202923: ucla1.batch1.PGCLCd1; Homo sapiens; RNA-Seq

SRX7267435 GSM4202923 GSM4202923: ucla1.batch1.PGCLCd1; Homo sapiens; RNA-Seq SRP234711 SRS5761930 GSM4202923 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202923 GSM4202923 GEO Accession GSM4202923 SRX7267436 GSM4202924 GSM4202924: ucla1.batch1.PGCLCd2; Homo sapiens; RNA-Seq SRP234711 SRS5761931 GSM4202924 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202924 GSM4202924 GEO Accession GSM4202924 SRX7267437 GSM4202925 GSM4202925: ucla1.batch1.PGCLCd3; Homo sapiens; RNA-Seq SRP234711 SRS5761932 GSM4202925 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202925 GSM4202925 GEO Accession GSM4202925 SRX7267438 GSM4202926 GSM4202926: ucla1.batch1.PGCLCd4; Homo sapiens; RNA-Seq SRP234711 SRS5761933 GSM4202926 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202926 GSM4202926 GEO Accession GSM4202926 SRX7267439 GSM4202927 GSM4202927: ucla1.batch1.hESC; Homo sapiens; RNA-Seq SRP234711 SRS5761934 GSM4202927 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202927 GSM4202927 GEO Accession GSM4202927 SRX7267440 GSM4202928 GSM4202928: ucla1.batch1.iMeLC; Homo sapiens; RNA-Seq SRP234711 SRS5761935 GSM4202928 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202928 GSM4202928 GEO Accession GSM4202928 SRX7267441 GSM4202929 GSM4202929: ucla1.batch2.PGCLCd1; Homo sapiens; RNA-Seq SRP234711 SRS5761936 GSM4202929 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202929 GSM4202929 GEO Accession GSM4202929 SRX7267442 GSM4202930 GSM4202930: ucla1.batch2.PGCLCd2; Homo sapiens; RNA-Seq SRP234711 SRS5761937 GSM4202930 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202930 GSM4202930 GEO Accession GSM4202930 SRX7267443 GSM4202931 GSM4202931: ucla1.batch2.PGCLCd3; Homo sapiens; RNA-Seq SRP234711 SRS5761938 GSM4202931 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202931 GSM4202931 GEO Accession GSM4202931 SRX7267444 GSM4202932 GSM4202932: ucla1.batch2.PGCLCd4; Homo sapiens; RNA-Seq SRP234711 SRS5761939 GSM4202932 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202932 GSM4202932 GEO Accession GSM4202932 SRX7267445 GSM4202933 GSM4202933: ucla1.batch2.hESC; Homo sapiens; RNA-Seq SRP234711 SRS5761940 GSM4202933 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202933 GSM4202933 GEO Accession GSM4202933 SRX7267446 GSM4202934 GSM4202934: ucla1.batch2.iMeLC; Homo sapiens; RNA-Seq SRP234711 SRS5761941 GSM4202934 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202934 GSM4202934 GEO Accession GSM4202934 SRX7267447 GSM4202935 GSM4202935: ucla1t2c.PGCLCd1; Homo sapiens; RNA-Seq SRP234711 SRS5761942 GSM4202935 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202935 GSM4202935 GEO Accession GSM4202935 SRX7267448 GSM4202936 GSM4202936: ucla1t2c.PGCLCd2; Homo sapiens; RNA-Seq SRP234711 SRS5761943 GSM4202936 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202936 GSM4202936 GEO Accession GSM4202936 SRX7267449 GSM4202937 GSM4202937: ucla1t2c.PGCLCd3; Homo sapiens; RNA-Seq SRP234711 SRS5761944 GSM4202937 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202937 GSM4202937 GEO Accession GSM4202937 SRX7267450 GSM4202938 GSM4202938: ucla1t2c.PGCLCd4; Homo sapiens; RNA-Seq SRP234711 SRS5761945 GSM4202938 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202938 GSM4202938 GEO Accession GSM4202938 SRX7267451 GSM4202939 GSM4202939: ucla1t2c.hESC; Homo sapiens; RNA-Seq SRP234711 SRS5761946 GSM4202939 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202939 GSM4202939 GEO Accession GSM4202939 SRX7267452 GSM4202940 GSM4202940: ucla1t2c.iMeLC; Homo sapiens; RNA-Seq SRP234711 SRS5761947 GSM4202940 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202940 GSM4202940 GEO Accession GSM4202940 SRX7267453 GSM4202941 GSM4202941: ucla2.batch1.PGCLCd1; Homo sapiens; RNA-Seq SRP234711 SRS5761948 GSM4202941 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202941 GSM4202941 GEO Accession GSM4202941 SRX7267454 GSM4202942 GSM4202942: ucla2.batch1.PGCLCd2; Homo sapiens; RNA-Seq SRP234711 SRS5761949 GSM4202942 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202942 GSM4202942 GEO Accession GSM4202942 SRX7267455 GSM4202943 GSM4202943: ucla2.batch1.PGCLCd3; Homo sapiens; RNA-Seq SRP234711 SRS5761950 GSM4202943 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202943 GSM4202943 GEO Accession GSM4202943 SRX7267456 GSM4202944 GSM4202944: ucla2.batch1.PGCLCd4; Homo sapiens; RNA-Seq SRP234711 SRS5761951 GSM4202944 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202944 GSM4202944 GEO Accession GSM4202944 SRX7267457 GSM4202945 GSM4202945: ucla2.batch1.hESC; Homo sapiens; RNA-Seq SRP234711 SRS5761952 GSM4202945 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202945 GSM4202945 GEO Accession GSM4202945 SRX7267458 GSM4202946 GSM4202946: ucla2.batch1.iMeLC; Homo sapiens; RNA-Seq SRP234711 SRS5761953 GSM4202946 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202946 GSM4202946 GEO Accession GSM4202946 SRX7267459 GSM4202947 GSM4202947: ucla2.batch2.PGCLCd1; Homo sapiens; RNA-Seq SRP234711 SRS5761954 GSM4202947 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202947 GSM4202947 GEO Accession GSM4202947 SRX7267460 GSM4202948 GSM4202948: ucla2.batch2.PGCLCd2; Homo sapiens; RNA-Seq SRP234711 SRS5761955 GSM4202948 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202948 GSM4202948 GEO Accession GSM4202948 SRX7267461 GSM4202949 GSM4202949: ucla2.batch2.PGCLCd3; Homo sapiens; RNA-Seq SRP234711 SRS5761956 GSM4202949 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202949 GSM4202949 GEO Accession GSM4202949 SRX7267462 GSM4202950 GSM4202950: ucla2.batch2.PGCLCd4; Homo sapiens; RNA-Seq SRP234711 SRS5761957 GSM4202950 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202950 GSM4202950 GEO Accession GSM4202950 SRX7267463 GSM4202951 GSM4202951: ucla2.batch2.hESC; Homo sapiens; RNA-Seq SRP234711 SRS5761958 GSM4202951 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202951 GSM4202951 GEO Accession GSM4202951 SRX7267464 GSM4202952 GSM4202952: ucla2.batch2.iMeLC; Homo sapiens; RNA-Seq SRP234711 SRS5761959 GSM4202952 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202952 GSM4202952 GEO Accession GSM4202952 SRX7267465 GSM4202953 GSM4202953: human_embryo_d12_rep1; Homo sapiens; RNA-Seq SRP234711 SRS5761960 GSM4202953 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202953 GSM4202953 GEO Accession GSM4202953 SRX7267466 GSM4202954 GSM4202954: human_embryo_d12_rep2; Homo sapiens; RNA-Seq SRP234711 SRS5761961 GSM4202954 RNA-Seq TRANSCRIPTOMIC cDNA Single cell suspension was made from hESCs, iMeLCs, day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 10X Genomics. Illumina NovaSeq 6000 gds 304202954 GSM4202954 GEO Accession GSM4202954 SRX7549659 GSM4257210_2 GSM4257210: ChIP_seq_TFAP2C_hESC_UCLA1_rep1; Homo sapiens; ChIP-Seq SRP234711 PRJNA593526 SRS5964380 SAMN13781050 ChIP-Seq GENOMIC ChIP ChIP-seq of hESCs, iMeLCs, day 4 aggregates was performed using anti-TFAP2C antibodies and libraries were constructed with Ovation Ultralow Systems V2 (NuGEN, 0344). ChIP-seq of sorted day4 hPGCLCs using anti-H3K27ac antibodies was performed using Low Cell ChIP-Seq Kit (ACTIVE MOTIF, 53804). Illumina HiSeq 4000 gds 304257210 GSM4257210 GEO Accession GSM4257210 SRX7549660 GSM4257211_2 GSM4257211: ChIP_seq_TFAP2C_hESC_UCLA1_rep2; Homo sapiens; ChIP-Seq SRP234711 PRJNA593526 SRS5964381 SAMN13781049 ChIP-Seq GENOMIC ChIP ChIP-seq of hESCs, iMeLCs, day 4 aggregates was performed using anti-TFAP2C antibodies and libraries were constructed with Ovation Ultralow Systems V2 (NuGEN, 0344). ChIP-seq of sorted day4 hPGCLCs using anti-H3K27ac antibodies was performed using Low Cell ChIP-Seq Kit (ACTIVE MOTIF, 53804). Illumina HiSeq 4000 gds 304257211 GSM4257211 GEO Accession GSM4257211 SRX7549661 GSM4257212_2 GSM4257212: ChIP_seq_TFAP2C_iMeLC_UCLA1_rep1; Homo sapiens; ChIP-Seq SRP234711 PRJNA593526 SRS5964382 SAMN13781048 ChIP-Seq GENOMIC ChIP ChIP-seq of hESCs, iMeLCs, day 4 aggregates was performed using anti-TFAP2C antibodies and libraries were constructed with Ovation Ultralow Systems V2 (NuGEN, 0344). ChIP-seq of sorted day4 hPGCLCs using anti-H3K27ac antibodies was performed using Low Cell ChIP-Seq Kit (ACTIVE MOTIF, 53804). Illumina HiSeq 4000 gds 304257212 GSM4257212 GEO Accession GSM4257212 SRX7549662 GSM4257213_2 GSM4257213: ChIP_seq_TFAP2C_iMeLC_UCLA1_rep2; Homo sapiens; ChIP-Seq SRP234711 PRJNA593526 SRS5964383 SAMN13781047 ChIP-Seq GENOMIC ChIP ChIP-seq of hESCs, iMeLCs, day 4 aggregates was performed using anti-TFAP2C antibodies and libraries were constructed with Ovation Ultralow Systems V2 (NuGEN, 0344). ChIP-seq of sorted day4 hPGCLCs using anti-H3K27ac antibodies was performed using Low Cell ChIP-Seq Kit (ACTIVE MOTIF, 53804). Illumina HiSeq 4000 gds 304257213 GSM4257213 GEO Accession GSM4257213 SRX7549663 GSM4257214_2 GSM4257214: ChIP_seq_TFAP2C_day4_aggregate_UCLA2_rep1; Homo sapiens; ChIP-Seq SRP234711 PRJNA593526 SRS5964384 SAMN13781046 ChIP-Seq GENOMIC ChIP ChIP-seq of hESCs, iMeLCs, day 4 aggregates was performed using anti-TFAP2C antibodies and libraries were constructed with Ovation Ultralow Systems V2 (NuGEN, 0344). ChIP-seq of sorted day4 hPGCLCs using anti-H3K27ac antibodies was performed using Low Cell ChIP-Seq Kit (ACTIVE MOTIF, 53804). Illumina HiSeq 4000 gds 304257214 GSM4257214 GEO Accession GSM4257214 SRX7549664 GSM4257215_2 GSM4257215: ChIP_seq_TFAP2C_day4_aggregate_UCLA2_rep2; Homo sapiens; ChIP-Seq SRP234711 PRJNA593526 SRS5964385 SAMN13781045 ChIP-Seq GENOMIC ChIP ChIP-seq of hESCs, iMeLCs, day 4 aggregates was performed using anti-TFAP2C antibodies and libraries were constructed with Ovation Ultralow Systems V2 (NuGEN, 0344). ChIP-seq of sorted day4 hPGCLCs using anti-H3K27ac antibodies was performed using Low Cell ChIP-Seq Kit (ACTIVE MOTIF, 53804). Illumina HiSeq 4000 gds 304257215 GSM4257215 GEO Accession GSM4257215 SRX7549665 GSM4257216_2 GSM4257216: ChIP_seq_H3K27ac_sorted_hPGCLCs_UCLA2_rep1; Homo sapiens; ChIP-Seq SRP234711 PRJNA593526 SRS5964386 SAMN13781044 ChIP-Seq GENOMIC ChIP ChIP-seq of hESCs, iMeLCs, day 4 aggregates was performed using anti-TFAP2C antibodies and libraries were constructed with Ovation Ultralow Systems V2 (NuGEN, 0344). ChIP-seq of sorted day4 hPGCLCs using anti-H3K27ac antibodies was performed using Low Cell ChIP-Seq Kit (ACTIVE MOTIF, 53804). Illumina HiSeq 4000 gds 304257216 GSM4257216 GEO Accession GSM4257216 SRX7549666 GSM4257217_2 GSM4257217: ChIP_seq_H3K27ac_sorted_hPGCLCs_UCLA2_rep2; Homo sapiens; ChIP-Seq SRP234711 PRJNA593526 SRS5964387 SAMN13781043 ChIP-Seq GENOMIC ChIP ChIP-seq of hESCs, iMeLCs, day 4 aggregates was performed using anti-TFAP2C antibodies and libraries were constructed with Ovation Ultralow Systems V2 (NuGEN, 0344). ChIP-seq of sorted day4 hPGCLCs using anti-H3K27ac antibodies was performed using Low Cell ChIP-Seq Kit (ACTIVE MOTIF, 53804). Illumina HiSeq 4000 gds 304257217 GSM4257217 GEO Accession GSM4257217 SRX7549667 GSM4257218_2 GSM4257218: ChIP_seq_H3K27ac_sorted_hPGCLCs_UCLA2_rep3; Homo sapiens; ChIP-Seq SRP234711 PRJNA593526 SRS5964388 SAMN13781042 ChIP-Seq GENOMIC ChIP ChIP-seq of hESCs, iMeLCs, day 4 aggregates was performed using anti-TFAP2C antibodies and libraries were constructed with Ovation Ultralow Systems V2 (NuGEN, 0344). ChIP-seq of sorted day4 hPGCLCs using anti-H3K27ac antibodies was performed using Low Cell ChIP-Seq Kit (ACTIVE MOTIF, 53804). Illumina HiSeq 4000 gds 304257218 GSM4257218 GEO Accession GSM4257218 SRX7549668 GSM4257219_2 GSM4257219: ChIP_seq_input_TFAP2C_day4_aggregate_UCLA2_rep1; Homo sapiens; ChIP-Seq SRP234711 PRJNA593526 SRS5964389 SAMN13781041 ChIP-Seq GENOMIC ChIP ChIP-seq of hESCs, iMeLCs, day 4 aggregates was performed using anti-TFAP2C antibodies and libraries were constructed with Ovation Ultralow Systems V2 (NuGEN, 0344). ChIP-seq of sorted day4 hPGCLCs using anti-H3K27ac antibodies was performed using Low Cell ChIP-Seq Kit (ACTIVE MOTIF, 53804). Illumina HiSeq 4000 gds 304257219 GSM4257219 GEO Accession GSM4257219 SRX7549669 GSM4257220_2 GSM4257220: ChIP_seq_input_TFAP2C_day4_aggregate_UCLA2_rep2; Homo sapiens; ChIP-Seq SRP234711 PRJNA593526 SRS5964390 SAMN13781040 ChIP-Seq GENOMIC ChIP ChIP-seq of hESCs, iMeLCs, day 4 aggregates was performed using anti-TFAP2C antibodies and libraries were constructed with Ovation Ultralow Systems V2 (NuGEN, 0344). ChIP-seq of sorted day4 hPGCLCs using anti-H3K27ac antibodies was performed using Low Cell ChIP-Seq Kit (ACTIVE MOTIF, 53804). Illumina HiSeq 4000 gds 304257220 GSM4257220 GEO Accession GSM4257220 SRX7549670 GSM4257221_2 GSM4257221: ChIP_seq_input_H3K27ac_sorted_hPGCLCs_UCLA2_rep1; Homo sapiens; ChIP-Seq SRP234711 PRJNA593526 SRS5964391 SAMN13781039 ChIP-Seq GENOMIC ChIP ChIP-seq of hESCs, iMeLCs, day 4 aggregates was performed using anti-TFAP2C antibodies and libraries were constructed with Ovation Ultralow Systems V2 (NuGEN, 0344). ChIP-seq of sorted day4 hPGCLCs using anti-H3K27ac antibodies was performed using Low Cell ChIP-Seq Kit (ACTIVE MOTIF, 53804). Illumina HiSeq 4000 gds 304257221 GSM4257221 GEO Accession GSM4257221